Kiwa Bio-Tech Announces Increased Sales and Income in its

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
46
Kiwa Bio-Tech Announces Increased Sales and Income in its Second Quarter

ONTARIO, CA--(Marketwired - Aug 15, 2017) - Kiwa Bio-Tech Products Group Corporation ( OTCQB : KWBT ) ("Kiwa" or the "Company"), a Company focused on eco-friendly biological fertilizers promoting harmless agriculture, released fiscal second quarter financial results that were driven by strong sales growth in Chinese market.

For the quarter ended June 30, 2017, the Company reported net income was $5,016,977 (including $4,513,363 one-time gain from discontinued operations), compared with $181,975 in the second quarter of 2016. 2017 second quarter revenue was $5,682,108, compared with $443,085 for the same period a year ago.

Key Highlights:

  • 2017 second quarter net income was $5,016,977 (including $4,513,363 one-time gain from discontinued operations), compared to net income of $181,975 in the second quarter of 2016.
  • 2017 second quarter net income from continuing operations increased 277% over 2016 second quarter net income from continuing operations.
  • 2017 second quarter revenue was $5,682,108, compared with $443,085 in the second quarter of 2016.
  • Our new biological organic fertilizer manufacturing base will commence operations at the end of 2017.
  • We expect to expand our 4 sales teams in various regions in China to increase market penetration and sales.

CEO Commentary

"We continue to see strong sales growth in our key markets on both a quarter-to-quarter and year-to-year basis. We believe that our growth derives from increasing demand for biological organic fertilizer products," said Kiwa CEO, Yvonne Wang. "To meet the need of this large and growing market, we expect that our new fertilizer manufacturing facility will commence operations by the end of 2017."

"During the second quarter of this fiscal year, the sales results exceeded our expectations and reached 25,500 tons of fertilizer products. This significant growth is due to the accomplishment of several milestones in our business plan. We plan to proactively adjust our product mix, expand our sales teams, and develop enhanced sales and marketing strategies in major agricultural areas of North, South and Central China. As a result, we believe that we can achieve our sales target of 100,000 tons of biological organic fertilizer products for the remainder of fiscal year 2017. At the same time, Kiwa is participating in establishing the standard system of harmless agriculture, which will have a significant impact on the development of agriculture in China," said Wang.

Market Outlook

  • In China, the biological organic fertilizer markets continue to grow due to increasing demand and strong consumption in most key economic crop planting regions in China. The tea-planting region in South and Central parts of China covers an area of approximately 3,320,000 mu (221,333 hectares) and the tobacco and orange planting areas in South China cover approximate 770,000 mu (51,333 hectares) and 2,557,498 mu (170,500 hectares) respectively.
  • The Chinese Ministry of Agriculture issued a notice "Implementation of the Plan to Use Organic Fertilizer on the Cultivation of Fruit, Vegetables and Tea" in April 2017. The notice created a requirement to use at least 50 % organic fertilizer in China's main planting areas of fruit, vegetables and tea by 2020 as a part of a program to replace chemical fertilizer with biological organic fertilizer.

About Kiwa Bio-Tech Products Group Corporation

Leader in Harmless Agricultural Industry Chain

Kiwa Bio-Tech Products Group Corporation develops, manufactures, distributes, and markets innovative, cost-effective and environmentally safe bio-technological products for agricultural and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes.

Kiwa is dedicated to eco-agricultural development and environmental control by developing, producing, and selling bio-technological products with high technology, low-cost, and high productivity to satisfy the growing market demand. Kiwa's development is creating a standardized and ecologically safe agricultural industry chain platform. The Company's development effort is based in China, and has gradually expanded to the international market.

Kiwa uses new bio-technological skills at its core, with organic, ecologically sound, and "green" practices as its theme. The Company strives for customer satisfaction and continued development. Kiwa is dedicated to making safe food, further developing eco-agriculture and upholding a responsibility of contributing to China's agricultural safety, food safety, and a healthy lifestyle. For more information on Kiwa and its products, please refer to the Company's website at www.kiwabiotech.com or the Company filings with the United States Securities and Exchange Commission, available for free at www.sec.gov .

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

CONTACT INFORMATION Kiwa Bio-Tech Products Group Corporation Molly Han molly@kiwabiotech.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cooper's Heat Pump Campaign Fuels Denver's Community

Updated Category News Views 124

How Heat Pumps Meet Philanthropy in Denver Alright, let me lay it out for you—a story as much about ingenuity as generosity. Cooper Heating & Cooling, donning their ‘Cooper Green Team’ capes, just wrapped up one heck of a community-driven campaign. They dropped a cool $5,000 into the coffers of We Don't Waste, a Denver nonprofit focused on food recovery. This...

Continue Reading
Ares Management Faces Fintech with $691B Assets

Updated Category News Views 170

Anticipation Builds: Ares Awaits TD Cowen Spotlight Ah, Ares Management, the Wall Street heavyweight clocking a colossal $691 billion in assets. Now, they’re angling to dish out some strategic insights. With the TD Cowen 2026 Financials & Fintech Conference set to roll on November 18, what’s better than watching these investment titans take the stage with their CFO...

Continue Reading
Surgery Partners and ADT Sales Under Legal Scrutiny

Updated Category News Views 6

Shareholder Scrutiny on Mergers It's no secret that corporate mergers often kick up a fuss, but when insiders get a juicy payday while regular shareholders play catch-up, folks raise eyebrows. Halper Sadeh LLC, that gutsy law firm, isn't shy about going after possible dirty deals, and they've got their eyes on a few names related to potential securities law violations and...

Continue Reading
BD Sets Stage for Investor Day in December 2026

Updated Category News Views 61

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Continue Reading
Gulliver Prep's New STEAM Complex to Transform Miami

Updated Category News Views 0

Gulliver Prep Leads the Charge in Education Innovation Gulliver Preparatory School just dropped a bombshell in Miami—almost literally, with their shovels hitting the dirt for a new 95,000-square-foot STEAM complex. It's not some lip-service to educational buzzwords either. This project's part of 'The Next 100: The Centennial Campaign for Gulliver,' a mega drive to...

Continue Reading
IASO Bio's In Vivo CAR-T: A Game Changer for Oncology?

Updated Category News Views 52

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

Continue Reading
Real Estate Decisions in Hospitality: Buy or Lease?

Updated Category News Views 0

Venturing into Hospitality Real Estate If you're in the hospitality game, the question of whether to buy or to lease your property can loom like a shadow or shine like an opportunity. The latest episode of the Owner's Edge Podcast by Bielat Santore & Company dives into this headfirst, armed with over 45 years of brokering experience in hospitality transactions. They don't...

Continue Reading
O-I Glass Faces Class Action: What Investors Must Know

Updated Category News Views 35

The Unsettling News for O-I Glass Investors Let me dive right into this mess about O-I Glass, Inc. (NYSE:OI). If you're tangled up in their stock, you probably felt that 15.01% nosedive in your portfolio recently. That's no minor blip. On July 28, 2026, as stocks were virtually put through the shredder, O-I Glass announced they had to cut down their financial guidance for...

Continue Reading
Gilat's Revenue Dip Spurs Legal Scrutiny for Investors

Updated Category News Views 51

Gilat Satellite's Surprise Revenue Shortfall If anybody thought the satellite business was all about science fiction-esque technology, here's a reality check: when earnings don't meet expectations, shareholders get jittery. This seems to be exactly what's happening with Gilat Satellite Networks Ltd. (NASDAQ: GILT). After twice reaffirming their fiscal 2026 revenue...

Continue Reading
Insulin Delivery Devices: A Billion-Dollar Surge

Updated Category News Views 20

When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...

Continue Reading

Top 5 Most Recently Viewed Articles

Embracing AI in Recruitment: A New Era for Job Seekers

Updated Category News Views 74

The Growing Impact of AI in Recruitment In today’s competitive job market, businesses are increasingly recognizing the benefits that artificial intelligence (AI) brings to the recruitment process. A recent survey found that a substantial portion—over 60%—of job seekers feel quite at ease with AI taking charge of the recruitment process. This involvement can span...

Continue Reading
Seagate Technology's Upcoming Earnings: What Investors Should Know

Updated Category News Views 90

Seagate Technology's Earnings Report Approaches Data storage innovator Seagate Technology (NASDAQ: STX) is set to announce its earnings results imminently, presenting investors with an important opportunity to assess the company’s performance. With high expectations surrounding this earnings release, understanding the key factors that might influence the report is...

Continue Reading
Revolutionary Blood Test For Early Alzheimer's Diagnosis Unveiled

Updated Category News Views 150

Innovative Blood Test for Alzheimer's Diagnosis A groundbreaking international research initiative is currently testing a finger prick blood test to aid in diagnosing Alzheimer's disease, potentially before symptoms manifest. This trial focuses on identifying three specific proteins in the blood connected to Alzheimer's, comparing results with the traditional diagnostic...

Continue Reading
AGNC Investment Prepares for Earnings Announcement

Updated Category News Views 139

Anticipating Earnings for AGNC Investment AGNC Investment (NASDAQ: AGNC) is gearing up to announce its quarterly earnings. Investors are eager to know the company's financial health and future outlook. According to analysts, AGNC Investment is projected to report an earnings per share (EPS) of $0.51 for this quarter. This figure is critical for investors tracking the...

Continue Reading
Investigation Launched into Nabors Industries Merger and Fairness

Updated Category News Views 175

Overview of the Investigation on Nabors Industries Ltd. Halper Sadeh LLC, a dedicated investor rights law firm, has initiated an investigation regarding the proposed merger between Nabors Industries Ltd. (NYSE: NBR) and Parker Wellbore. The focus of this inquiry is to determine whether the terms of this merger are fair to the shareholders of Nabors Industries. This...

Continue Reading